Opus Genetics, Inc. (IRD) stock
IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.05+0.01 (+0.25%)
Close on Nov 17, 2026Market cap $336.94MP/E –Yield –
Opus Genetics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Opus Genetics's pe ratio was 2.1× on Jan 31, 2024.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 2.1× | −0.3 |
| 2023 | Dec 29, 2023 | 2.4× | – |
See a number that looks wrong?